← Leaderboards
Hua Xie
Meharry Medical College
$6,448,692
Attributed
$6,448,692
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,448,692 · 11
By mechanism
U54$3,175,784 · 4
R01$1,422,474 · 2
R21$1,231,660 · 3
R16$436,500 · 1
K08$182,274 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Periodontitis”
- Georgios Hajishengallis · University Of Pennsylvania$28,284,116
- Richard J Lamont · Research Inst Nationwide Children'S Hosp$23,766,749
- Salomon Amar · Boston Medical Center$18,335,188
- Thomas E Van Dyke · Boston University Medical Campus$17,793,622
- Steven Nmn Offenbacher · University Of North Carolina Chapel Hill$17,786,424
- Ricardo P Teles · Beth Israel Deaconess Medical Center$17,089,524
Research focus
PeriodontitisPorphyromonas GingivalisLeadBacteriaSignaling MoleculeMicrobial BiofilmsGenesAffectCellsDental PlaqueAdultBasePathogenStreptococcus CristatusMembrane ProteinsIncidencePeriodontal DiseasesCommunicationProductionFutureOralLaboratoriesDesignExhibits
Grant awards (28)
Development and characterization of anti-P. gingivalis peptides$145,500
R16 · FY2025 · GM · contact PI
Development and characterization of anti-P. gingivalis peptides$145,500
R16 · FY2024 · GM · contact PI
Development and characterization of anti-P. gingivalis peptides$145,500
R16 · FY2023 · GM · contact PI
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities$297,263
U54 · FY2021 · MD · contact PI
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities$297,679
U54 · FY2020 · MD · contact PI
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities$41,754
U54 · FY2020 · MD · contact PI
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities$41,274
U54 · FY2020 · MD · contact PI
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities$318,719
U54 · FY2019 · MD · contact PI
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities$318,899
U54 · FY2018 · MD · contact PI
Impact of prevalence of P. gingivalis and S. cristatus in oral health disparities$307,062
U54 · FY2017 · MD · contact PI
Identification of cyclic di-GMP signaling components in P. gingivalis$181,875
R21 · FY2016 · DE · contact PI
Identification of cyclic di-GMP signaling components in P. gingivalis$218,250
R21 · FY2015 · DE · contact PI
Distribution correlation of P. gingivalis and S. cristatus in dental plaque$176,160
R21 · FY2013 · DE · contact PI
Distribution correlation of P. gingivalis and S. cristatus in dental plaque$231,375
R21 · FY2012 · DE · contact PI
Identification of a novel signaling network in Porphyromonas gingivalis$187,875
R21 · FY2012 · DE · contact PI
Identification of a novel signaling network in Porphyromonas gingivalis$236,125
R21 · FY2011 · DE · contact PI
Intergeneric Signaling Molecules of S. cristatus$165,436
R01 · FY2008 · DE · contact PI
ANTI-HIV ACTIVITY OF P GINGIVALIS$223,704
U54 · FY2007 · RR · contact PI
Intergeneric Signaling Molecules of S. cristatus$167,277
R01 · FY2007 · DE · contact PI
ANTI-HIV ACTIVITY OF P GINGIVALIS$350,916
U54 · FY2006 · RR · contact PI
Intergeneric Signaling Molecules of S. cristatus$172,273
R01 · FY2006 · DE · contact PI
SUBPROJECT 1$978,514
U54 · FY2005 · RR
Intergeneric Signaling Molecules of S. cristatus$176,419
R01 · FY2005 · DE
Intergeneric Signaling Molecules of S. cristatus$176,419
R01 · FY2004 · DE
Inhibition of HIV Infection by Oral Bacterial Component$282,325
R01 · FY2003 · DE
Inhibition of HIV Infection by Oral Bacterial Component$282,325
R01 · FY2002 · DE
REGULATION OF THE P GINGIVALIS FIMA GENE$105,191
K08 · FY2001 · DE
REGULATION OF THE P GINGIVALIS FIMA GENE$77,083
K08 · FY2000 · DE